According to the 2019 J.P. Morgan conference playbook released in advance of the investment bank's 37th annual health care meeting in San Francisco, over the past 18 years the NYSE Arca Biotech Index (BTK) outperformed the S&P 500 index approximately 78 percent of the time during event week. With the curtain now closed on the JPM meeting, the public companies involved in the sector will be pleased to learn that this statistic held true for another year. Read More
Despite a rough ride on the capital markets, particularly in the second half of the year, the biopharmaceutical sector had no difficulty in attracting capital. According to BioWorld data, the $67.1 billion that was raised by global companies from public and private sources in 2018 was just shy of the leading total of $68.4 billion generated in 2015 and places it firmly in second place in terms of totals raised in the history of the industry. Read More